Ibex Biosciences, LLC ("Ibex") is headquartered in North Bethesda, Maryland. Unusual for early-stage biotechnology companies, Ibex engages in a diverse approach to research and development.

​

Ibex strives to discover, validate, and produce potential solutions to a multitude of serious challenges facing human health by investing in exploratory projects and processes that may not have been validated within the public research community. 

​

Ibex's mission is the relentless pursuit to effectively treat unmet medical conditions plaguing humanity.

Ibex has a portfolio of therapeutic antibodies, gene therapies and regeneration programs. Additionally, Ibex is developing a diagnostic to increase the reliability of biopsies.